Related Experiment Video

Updated: Nov 10, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.1K

MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma

Lisa Kinget1, Eduard Roussel2, Diether Lambrechts3,4

  • 1Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000 Leuven, Belgium.

Cancers
|April 3, 2021
PubMed

Insights

Certain microRNAs (miRNAs) are linked to bone metastasis in clear-cell renal cell carcinoma (ccRCC). Specific miRNAs may predict earlier or less frequent bone metastasis, offering new therapeutic targets for ccRCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bone metastasis in clear-cell renal cell carcinoma (ccRCC) significantly increases patient morbidity and worsens prognosis.
  • MicroRNAs (miRNAs) are key regulators in cancer progression and metastasis.

Purpose of the Study:

  • To identify specific microRNAs (miRNAs) dysregulated in ccRCC that are associated with bone metastasis.
  • To explore the potential of these miRNAs as biomarkers and therapeutic targets for metastatic ccRCC.

Main Methods:

  • Retrospective analysis of microRNA expression profiles in ccRCC patients.
  • Correlation analysis between specific miRNA levels and the occurrence and timing of bone metastasis.

Main Results:

  • Dysregulated miRNAs were identified in ccRCC associated with bone metastasis.
  • miR-23a-3p, miR-27a-3p, miR-20a-5p, and miR-335-3p correlated with earlier bone metastasis.
  • miR-30b-3p and miR-139-3p correlated with a lower incidence of bone metastasis.

Conclusions:

  • Specific miRNAs can serve as potential biomarkers for predicting bone metastasis in ccRCC.
  • Targeting these miRNAs with inhibitors or mimics may offer novel therapeutic strategies for bone-targeted treatment in metastatic ccRCC.
Keywords:
SATB2bone metastasismiR-139-3pmiR-20a-5pmiR-23a-3pmiR-27a-3pmiR-30b-3pmiR-335-3pmicroRNArenal cell carcinoma

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

9.2K
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.4K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K